Cadrenal Therapeutics, Inc.
New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Jul 25, 2022
Total Offering
$2,000,000
Amount Sold
$150,000
Investors
2
First Sale
Jul 12, 2022
Offering Details
- Type
- Debt, Security to be Acquired, Other: 6% Convertible Note convertible into shares of common stock upon close of IPO
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Quang Pham | Related Person |
| Matthew Szot | Related Person |
Company
SEC Filing
0001213900-22-041222
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free